Polydrug Laboratories Private Limited
Polydrug Laboratories Private Limited is a Private Indian company incorporated in 2004 and based in Maharashtra, India. Polydrug Laboratories Private Limited operates in Pharmaceuticals & Chemicals (NIC 24231) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
POLYDRUG LABORATORIES PRIVATE LIMITED is the legal entity of polydrug.com.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Polydrug Laboratories Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 22 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +36d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 23 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Polydrug Laboratories Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 939076002 | ICICI Bank Ltd(Bank) | ₹8.89 Cr | 04 Jul 2022 | Satisfied |
| 426503176 | State Bank of India(Bank) | ₹24.98 Cr | 04 Jul 2022 | Satisfied |
| 730227073 | Kotak Mahindra Bank Ltd(Bank) | ₹14.07 Cr | 27 Jan 2022 | Open |
| 798063948 | Axis Bank Ltd(Bank) | ₹8.22 Cr | 19 Sep 2019 | Open |
| 574555137 | ICICI Bank Ltd(Bank) | ₹22.95 Cr | 27 Jan 2021 | Open |
| 663730249 | State Bank of India(Bank) | ₹23.74 Cr | 12 Mar 2020 | Satisfied |
Charge IDs, lenders & amounts for Polydrug Laboratories Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹11.95 Cr | ₹9.67 L | ₹6.40 Cr | ₹12.84 Cr | 247 |
| FY2023-24 | ₹9.85 Cr | ₹-25.14 L | ₹8.61 Cr | ₹15.08 Cr | 293 |
| FY2022-23 | ₹8.54 Cr | ₹-2.69 L | ₹3.56 Cr | ₹9.97 Cr | 219 |
| FY2021-22 | ₹8.77 Cr | ₹-12.08 L | ₹7.54 Cr | ₹11.94 Cr | 254 |
Audited financials & ratios for Polydrug Laboratories Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹11.95 Cr | ₹9.85 Cr | ₹8.54 Cr | ₹8.77 Cr |
| Other income | ₹30.40 L | ₹25.39 L | ₹23.12 L | ₹16.04 L |
| Total income | ₹12.25 Cr | ₹10.11 Cr | ₹8.77 Cr | ₹8.93 Cr |
| Total expenses | ₹12.13 Cr | ₹10.43 Cr | ₹8.81 Cr | ₹9.08 Cr |
| Profit before tax | ₹12.57 L | ₹-32.69 L | ₹-3.50 L | ₹-15.71 L |
| Profit / (Loss) after tax | ₹9.67 L | ₹-25.14 L | ₹-2.69 L | ₹-12.08 L |
| Balance sheet | ||||
| Equity / Net worth | ₹6.40 Cr | ₹8.61 Cr | ₹3.56 Cr | ₹7.54 Cr |
| Borrowings | ₹1.35 Cr | ₹2.63 Cr | ₹3.25 Cr | ₹1.04 Cr |
| Current liabilities | ₹3.84 Cr | ₹3.54 Cr | ₹2.97 Cr | ₹1.52 Cr |
| Total liabilities | ₹6.45 Cr | ₹6.47 Cr | ₹6.41 Cr | ₹4.40 Cr |
| Current assets | ₹7.40 Cr | ₹5.62 Cr | ₹4.78 Cr | ₹6.83 Cr |
| Cash & equivalents | ₹1.91 Cr | ₹1.63 Cr | ₹1.15 Cr | ₹2.66 Cr |
| Total assets | ₹12.84 Cr | ₹15.08 Cr | ₹9.97 Cr | ₹11.94 Cr |
| Employees | 247 | 293 | 219 | 254 |
Audited financials & ratios for Polydrug Laboratories Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹11.95 Cr | -6.5% | -6.0% | -1.8% |
| Profit after Tax | ₹9.67 L | -11.7% | +10.1% | +18.0% |
| Net Worth | ₹6.40 Cr | +3.9% | +21.3% | +3.7% |
| Employees | 247 | -2.1% | +19.7% | +9.4% |
Audited financials & ratios for Polydrug Laboratories Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹11.95 Cr | ₹9.67 L | +0.81% | -2.93% | +1.51% | +0.75% | 0.21 | ₹4.84 L |
| FY2023-24 | ₹9.85 Cr | ₹-25.14 L | -2.55% | +25.92% | -2.92% | -1.67% | 0.31 | ₹3.36 L |
| FY2022-23 | ₹8.54 Cr | ₹-2.69 L | -0.32% | +18.32% | -0.76% | -0.27% | 0.91 | ₹3.90 L |
| FY2021-22 | ₹8.77 Cr | ₹-12.08 L | -1.38% | -8.36% | -1.60% | -1.01% | 0.14 | ₹3.45 L |
Audited financials & ratios for Polydrug Laboratories Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 1,37,14,583 | 89.98% |
| Institutional Investors | 1 | 3,41,644 | 2.24% |
| Public & Others | 36 | 11,85,613 | 7.78% |
Promoter, institutional & public holding for Polydrug Laboratories Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
91 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.